journal article Open Access Jan 01, 2020

The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis

View at Publisher Save 10.1016/j.jvir.2019.08.035
Topics

No keywords indexed for this article. Browse by subject →

References
37
[1]
Ahmed "Hemodialysis access maintenance in the medicare population: an analysis over a decade of trends by provider specialty and site of service" J Vasc Interv Radiol (2018) 10.1016/j.jvir.2017.09.028
[2]
Thamer "Medicare costs associated with arteriovenous fistulas among us hemodialysis patients" Am J Kidney Dis (2018) 10.1053/j.ajkd.2018.01.034
[3]
Tessitore "Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study" Nephrol Dial Transplant (2004) 10.1093/ndt/gfh316
[4]
Tessitore "Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study" Nephrol Dial Transplant (2008) 10.1093/ndt/gfn275
[5]
Moist "Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival" J Am Soc Nephrol (2003) 10.1097/01.asn.0000089562.98338.60
[6]
Ravani "Pre-emptive correction for haemodialysis arteriovenous access stenosis" Cochrane Database Syst Rev (2016) 10.1002/14651858.cd010709.pub2
[7]
McCarley "Vascular access blood flow monitoring reduces access morbidity and costs" Kidney Int (2001) 10.1046/j.1523-1755.2001.0600031164.x
[8]
Dember "Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis" Kidney Int (2004) 10.1111/j.1523-1755.2004.00743.x
[9]
Malik "Regular ultrasonographic screening significantly prolongs patency of PTFE grafts" Kidney Int (2005) 10.1111/j.1523-1755.2005.00236.x
[10]
Rayner "Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)" Am J Kidney Dis (2014) 10.1053/j.ajkd.2014.01.014
[11]
Cohen "Anxiety in patients treated with hemodialysis" Clin J Am Soc Nephrol (2016) 10.2215/cjn.02590316
[12]
Domenick Sridharan "The associations of hemodialysis access type and access satisfaction with health-related quality of life" J Vasc Surg (2018) 10.1016/j.jvs.2017.05.131
[13]
Vesely "Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts" J Vasc Surg (2016) 10.1016/j.jvs.2016.04.035
[14]
Haskal "Stent graft versus balloon angioplasty for failing dialysis-access grafts" N Engl J Med (2010) 10.1056/nejmoa0902045
[15]
Haskal "Prospective, randomized, concurrently-controlled study of a stent graft versus balloon angioplasty for treatment of arteriovenous access graft stenosis: 2-year results of the RENOVA Study" J Vasc Interv Radiol (2016) 10.1016/j.jvir.2016.05.019
[16]
Falk "A prospective, randomized study of an expanded polytetrafluoroethylene stent graft versus balloon angioplasty for in-stent restenosis in arteriovenous grafts and fistulae: two-year results of the RESCUE Study" J Vasc Interv Radiol (2016) 10.1016/j.jvir.2016.06.014
[17]
Kitrou "Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial" J Vasc Interv Radiol (2015) 10.1016/j.jvir.2014.11.003
[18]
Kitrou "Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472)" Eur J Radiol (2015) 10.1016/j.ejrad.2014.11.037
[19]
Swinnen "Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses" J Vasc Access (2019) 10.1177/1129729818801556
[20]
Irani "Hemodialysis arteriovenous fistula and graft stenoses: randomized trial comparing drug-eluting balloon angioplasty with conventional angioplasty" Radiology (2018) 10.1148/radiol.2018170806
[21]
Katsanos "Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial" J Endovasc Ther (2012) 10.1583/11-3690.1
[22]
Kitrou "Paclitaxel-coated balloons for the treatment of symptomatic central venous stenosis in dialysis access: results from a randomized controlled trial" J Vasc Interv Radiol (2017) 10.1016/j.jvir.2017.03.007
[23]
Lai "Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study" J Vasc Interv Radiol (2014) 10.1016/j.jvir.2013.12.014
[24]
Trerotola "Drug coated balloon angioplasty in failing av fistulas: a randomized controlled trial" Clin J Am Soc Nephrol (2018) 10.2215/cjn.14231217
[25]
Katsanos "Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials" J Am Heart Assoc (2018)
[26]
Gray "Reporting standards for percutaneous interventions in dialysis access" J Vasc Interv Radiol (2003) 10.1097/01.rvi.0000094618.61428.58
[27]
Kim "Analysis of infection risk following covered stent exclusion of pseudoaneurysms in prosthetic arteriovenous hemodialysis access grafts" J Vasc Interv Radiol (2012) 10.1016/j.jvir.2011.09.003
[28]
"Clinical practice guidelines for vascular access" Am J Kidney Dis (2006)
[29]
Trerotola "Statement of clarification: drug coated balloon angioplasty in failing AV fistulas" Clin J Am Soc Nephrol (2019) 10.2215/cjn.05990519
[30]
Maleux "Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae" J Vasc Interv Radiol (2018) 10.1016/j.jvir.2017.10.023
[31]
Bjorkman "Drug-coated versus plain balloon angioplasty in arteriovenous fistulas: a randomized, controlled study with 1-year follow-up (the Drecorest Ii-Study)" Scand J Surg (2019) 10.1177/1457496918798206
[32]
Kim "Factors affecting patency following successful percutaneous intervention for dysfunctional hemodialysis vascular access" Ann Vasc Surg (2018) 10.1016/j.avsg.2017.08.003
[33]
Trivedi "Race and sex disparities in outcomes of dialysis access maintenance interventions" J Vasc Interv Radiol (2018) 10.1016/j.jvir.2017.10.018
[34]
Aktas "Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency" Diagn Interv Radiol (2015) 10.5152/dir.2014.14348
[35]
United States Renal Data System. 2018 USRDS Annual Data Report: epidemiology of kidney disease in the United States. 2018. Available at: https://www.usrds.org/adr.aspx. Accessed October 30, 2019.
[36]
Kennedy "Drug-coated balloon angioplasty in hemodialysis circuits: a systematic review and meta-analysis" J Vasc Interv Radiol (2019) 10.1016/j.jvir.2019.01.012
[37]
Sachdeva "Drug-coated balloon angioplasty for hemodialysis fistula maintenance" Clin J Am Soc Nephrol (2018) 10.2215/cjn.07360618
Cited By
93
Metrics
93
Citations
37
References
Details
Published
Jan 01, 2020
Vol/Issue
31(1)
Pages
1-14.e5
License
View
Funding
Lutonix
Cite This Article
Scott O. Trerotola, Theodore F. Saad, Prabir Roy-Chaudhury (2020). The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis. Journal of Vascular and Interventional Radiology, 31(1), 1-14.e5. https://doi.org/10.1016/j.jvir.2019.08.035